// App-Quantinova.ai

737 : An RCT of Rilpivirine vs Efavirenz on Cardiovascular Risk in Healthy Volunteers

Researchers

Presenter

  • Samir K. Gupta

Principal Investigators

  • James E. Slaven

  • Ziyue Liu

Medical Centers

  • Medicine/Infectious Diseases, Indiana University School of Medicine, Indianapolis, IN, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • High sensitivity C-reactive protein

  • Interleukin 6

  • Soluble Vascular Cell Adhesion Molecule-1

Drug/Treatment

  • Nitroglycerin

  • Adesitrin

  • Rilpivirine

  • Efavirenz

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved